Osteonecrosis of the Jaw in a Patient With Bone Metastatic Prostate Cancer After Long-term Bisphosphonate Treatment With Severe Deterioration Following Radium-223

Clin Genitourin Cancer. 2018 Oct;16(5):328-331. doi: 10.1016/j.clgc.2018.05.003. Epub 2018 May 16.

¹ Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, Oslo, Norway; Division for Head, Neck, and Reconstructive Surgery, Department of Otorhinolaryngology - Head and Neck Surgery, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
² Private Practice in Oral Surgery and Oral Medicine, Hamar, Norway.
³ Division for Head, Neck, and Reconstructive Surgery, Department of Otorhinolaryngology - Head and Neck Surgery, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
⁴ Department of Nuclear Medicine, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
⁵ Department of Oncology, Norwegian Radium Hospital, Oslo University Hospital and Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Electronic address: osb@ous-hf.no.

No abstract available

Keywords: Adverse event; Bone metastases; Castrate-resistant prostate cancer; Combination therapy; Jaw necrosis.

Publication types